JACOBS LEVY EQUITY MANAGEMENT, INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$4,583,000
-56.0%
295,276
-54.0%
0.03%
-61.2%
Q1 2021$10,415,000
+1811.0%
642,475
+2394.3%
0.08%
+1500.0%
Q4 2020$545,000
+55.3%
25,758
-14.0%
0.01%0.0%
Q1 2020$351,000
+83.8%
29,938
+183.5%
0.01%
+25.0%
Q2 2016$191,000
-74.0%
10,560
-72.7%
0.00%
-75.0%
Q1 2016$734,00038,6600.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders